Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data
- PMID: 11768291
- DOI: 10.1023/a:1012247131190
Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data
Abstract
The purpose of this study was to examine how best to incorporate plasma samples which fall below an assay's lower limit of quantification into the process of toxicokinetic data modeling. Secondly to establish what proportion of data can be below the quantification limit without compromising NONMEM's parameter estimates. Using pharmacokinetic parameters determined in a rat toxicokinetic study we simulated datasets that might emerge from similar experiments in which only one sample was obtained per individual. A number of quantification limits were used which resulted in increasing proportions of data values being treated as if they were below the limit of quantification (BQL). For each quantification level we incorporated BQL data into our analyses in number of ways. We compared these analysis methods with respect to how well the underlying parameter values were retrieved. Omitting BQL data values or entering them as zero led to inaccurate and biased study results. We found that incorporating BQL values using more complex substitution methods via a mixed effects model produced more reliable and less biased parameter estimates. The four substitution methods that we investigated performed similarly. Parameter estimates became less reliable and more biased as the quantification level was increased depending on the method of BQL value incorporation. Naive methods of BQL data handling can produce unreliable and biased parameter estimates. An alternative is to incorporate BQL values into a population-type model, our results showed this method to be preferable. We found it advisable that the proportion of BQL data should not exceed one third and, if possible should be less than one quarter.
Similar articles
-
Ways to fit a PK model with some data below the quantification limit.J Pharmacokinet Pharmacodyn. 2001 Oct;28(5):481-504. doi: 10.1023/a:1012299115260. J Pharmacokinet Pharmacodyn. 2001. PMID: 11768292
-
Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data.Pharm Stat. 2010 Oct-Dec;9(4):313-30. doi: 10.1002/pst.400. Pharm Stat. 2010. PMID: 20043295
-
Handling data below the limit of quantification in mixed effect models.AAPS J. 2009 Jun;11(2):371-80. doi: 10.1208/s12248-009-9112-5. Epub 2009 May 19. AAPS J. 2009. PMID: 19452283 Free PMC article.
-
Pharmacodynamic parameter estimation: population size versus number of samples.AAPS J. 2005 Oct 5;7(2):46. doi: 10.1208/aapsj070246. AAPS J. 2005. PMID: 16353905 Free PMC article. Review.
-
Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.Health Technol Assess. 2001;5(33):1-56. doi: 10.3310/hta5330. Health Technol Assess. 2001. PMID: 11701102 Review.
Cited by
-
Approaches to handling missing or "problematic" pharmacology data: Pharmacokinetics.CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):291-308. doi: 10.1002/psp4.12611. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33715307 Free PMC article.
-
Clinical trial simulation to evaluate power to compare the antiviral effectiveness of two hepatitis C protease inhibitors using nonlinear mixed effect models: a viral kinetic approach.BMC Med Res Methodol. 2013 Apr 25;13:60. doi: 10.1186/1471-2288-13-60. BMC Med Res Methodol. 2013. PMID: 23617810 Free PMC article.
-
Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?Cancers (Basel). 2023 May 23;15(11):2875. doi: 10.3390/cancers15112875. Cancers (Basel). 2023. PMID: 37296838 Free PMC article.
-
Population pharmacokinetics of cabotegravir following intramuscular thigh injections in adults with and without HIV.Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0088024. doi: 10.1128/aac.00880-24. Epub 2024 Oct 23. Antimicrob Agents Chemother. 2024. PMID: 39440971 Free PMC article. Clinical Trial.
-
Prophylactic ranitidine treatment in critically ill children--a population pharmacokinetic study.Br J Clin Pharmacol. 2013 May;75(5):1265-76. doi: 10.1111/j.1365-2125.2012.04473.x. Br J Clin Pharmacol. 2013. PMID: 23016949 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources